IPO Issue Details
Issue Price / Price Band₹35 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size4,000 Shares per Lot
Total Issue Size20,00,000 shares (aggregating up to ₹7.00 Cr)
Issue TypeFixed Price IPO
Sale Type / CategoryFresh Capital
Exchange / PlatformBSE SME
IPO TypeSME
Subscription OpenWed, 05 Jun 2024
Subscription CloseFri, 07 Jun 2024
Anchor AllotmentTue, 04 Jun 2024
Basis of AllotmentMon, 10 Jun 2024
Initiation of RefundsTue, 11 Jun 2024
Credit of Shares to DematTue, 11 Jun 2024
Listing DateWed, 12 Jun 2024
UPI Mandate Deadline2024-06-07
Application & Investment Details
Retail — Min (1 Lots)₹1,40,000 — 4,000 shares
Retail — Max (13 Lots)₹1,820,000 (13 Lots)
HNI — Min (2 Lots)₹2,80,000 — 8,000 shares
EPS (Pre-IPO)₹0.50
EPS (Post-IPO)₹0.47
P/E Ratio (Pre-IPO)69.43x
P/E Ratio (Post-IPO)74.03x
Net Offer to Public18,96,000 shares (aggregating up to ₹6.64 Cr)
Reserved for Market Maker1,04,000 shares (aggregating up to ₹0.3640 Cr)
Pre-IPO Promoter Holding48,69,936 shares
Post-IPO Promoter Holding68,69,936 shares
About Magenta Lifecare Ltd
Incorporated in 2015, Magenta Lifecare Limited manufactures mattresses and pillows. The company offers foam-based products under the brand "Magenta" in India.Magenta Lifecare's product portfolio includes memory foam, latex-based, bonded mattresses, pocketed springs etc. and pillows such as memory foam pillows, moulded memory foam pillows, moulded contour foam pillows etc.Magenta Lifecare Limited's manufacturing facility is located in Gujarat, India. The installed capacity for manufacturing mattresses is currently at 60,000 Nos. and 70,000 nos. of pillows.As of May 2024, the company's overall staff strength is 41 employees. The products the company offers to the customers are spread across retail, hotels and institutions.Competitive Strengths:Diversified customer base and long-standing relationship with the customers.Extensive and well-developed pan-India sales and distribution network.Diversified Product portfolio.Experienced Promoter Directors with extensive domain knowledge.Quality assurance and accreditations.
Objects of the Issue
Magenta Lifecare Ltd proposes to utilise the net proceeds from the Issue for the following objects:
1
. Funding our working capital requirements; and
2
. General corporate purposes
Shareholding & Lock-in
Pre-IPO Promoter Holding
48,69,936 shares
Post-IPO Promoter Holding
68,69,936 shares